Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05705557

Efficacy of ABSOLOK™ Clip System-RFP-2021-01 in Open Liver Resection

The purpose of this prospective observational study is to evaluate the incidence of Post-Operative Bile Leakage (POBL) using the ABSOLOK™ Clip System during liver parenchymal resection by evaluating the intraoperative and short-term postoperative results. In addition, it will attempt to determine the factors that determine the surgeon's peripheral glissonian pedicle closure method and economic outcomes.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Roma, RM, 00168, Italy

Location status: Recruiting

Location contact

Agostino Maria De Rose, MD, PhD

CONTACT

[email protected]

+39 0630155855

Agostino Maria De Rose, MD, PhD

SUB_INVESTIGATOR

Felice Giuliante, MD

PRINCIPAL_INVESTIGATOR

Francesco Ardito, MD, PhD

SUB_INVESTIGATOR

Simone Vani, BSc

CONTACT

[email protected]

+39 0630155642

About this study

Over the last two decades, significant advances have been made in hepatectomy because of advancements in surgical techniques and improvement on parenchymal transection. Modern liver surgeon must be equipped with excellent theoretical and clinical skills to perform a safe liver resection. Despite significant technical advancements in the field of liver surgery, bile leakage remains a significant postoperative morbidity. Although the exact post-hepatectomy bile leakage site is not clear, bile leakage reportedly occurs in 3-12% according to the kind of resection.

Recently, in a large multicenter retrospective series, including 13.379 resected patients, the overall incidence of post-operative bile leakage (POBL) is 6%, significantly higher after open versus laparoscopic approach, respectively 9,4% vs 3,1% (p<0.001). POBL was defined according to the 2010 International Study Group of Liver Surgery (ISGLS) and it was categorized in three grades of severity (grade A, B, C) and clinically relevant POBL (CR-POBL) was defined as grade B and C. CR-POBL is associated with increased length of post-operative stay and can be associated with subsequent severe complications such as intra-abdominal abscess, peritonitis, and sepsis. In the case of anatomical liver resection, most of the leakage points are observed around the hilar Glissonean stump and not at the peripheral parenchymal cutting plane, because parenchymal resection is usually performed along the intersegmental plane.

Recently, parenchyma-sparing hepatectomy (PSH) has become a gold standard treatment for colorectal liver metastases (CLM). PSH is associated with better perioperative outcomes without compromising oncological outcomes and given the relatively high incidence of hepatic parenchymal recurrence, the PSH treatment offers a greater opportunity of repeat resection for intrahepatic recurrences.

Anatomic resection (AR) remains the gold standard surgical treatment for hepatocellular carcinoma (HCC) in patients with a well-preserved liver function because postoperative recurrence is usually caused by micrometastases around the tumor therefore resecting the tumor-bearing portal branches and the corresponding liver parenchyma achieving better local control. US-guided limited resection (LR) and AR may be chosen and/or combined by the surgeon for the other surgical indications. Most of the leakage points are observed at the peripheral parenchymal cutting plane despite the liver parenchymal transection was carried out using the ultrasonic dissector and all peripheral glissonian pedicles (≥ 2-3 mm) were separately isolated, clipped or ligated and transected.

The aim of the prospective study is to assess the incidence of POBL using ABSOLOK™ Clip System during parenchymal liver transection, evaluating intra-operative and short-term post-operative results. In addition, the factors that determine the surgeon's peripheral glissonian pedicle closure method and cost results will be tried to be determined.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 18 years;
  • Subject has given his informed consent and signed consent;
  • Patients undergoing open liver resection.

Exclusion criteria

  • Surgery made in emergency;
  • Surgery by laparoscopy;
  • Need to perform a bilio-digestive anastomosis;
  • Preoperative jaundice (total bilirubin > 3 mg/mL).

Treatment and study plan

ABSOLOK™ Clip System

Device

Use of ABSOLOK™ Clip System during parenchymal transection for open liver resection

Primary outcomes

  1. Incidence of Overall Post-Operative Bile Leakage (POBL) using ABSOLOK™ Clips during liver resection

    Time frame: 90 days

    Participants will be followed for the duration of hospital stay and Follow Up

Secondary outcomes

  1. Duration of POBL (Post-operative bile leakage) and the timing of drainage removal

    Time frame: 90 days

    Participants will be followed for the duration of hospital stay and Follow Up

  2. Additional maneuvers for treat biliary fistula

    Time frame: 90 days

    Participants will be followed for the duration of hospital stay and Follow Up

  3. Lenght of post-operative stay

    Time frame: 90 days

    Participants will be followed for the duration of hospital stay

  4. Rate of post-operative Morbidity

    Time frame: 90 days

    Participants will be followed for the duration of hospital stay and Follow Up

  5. Rate of post-operative Mortality

    Time frame: 90 days

    Assessment of mortality during the hospitalization or Follow Up

Study contacts

Contact information is provided by the study sponsor or research team.

Agostino Maria De Rose, MD, PhD

CONTACT

[email protected]

+39 0630155855

Felice Giuliante, MD

CONTACT

[email protected]

+39 0630156857

Sponsors and collaborators

Lead sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Other

Collaborators

  • Ethicon, Inc.

Registry information

Official study title

Assessment of Efficacy of ABSOLOK™ Clip System-RFP-2021-01 in Achieving BIliostasis During Parenchymal Transection for Open Liver Resection

Acronym: EBILROK

Important dates

Study start
2023
Primary completion
2025
Study completion
2026
First posted
Jan 31, 2023
Registry last updated
Aug 14, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.